Insider Selling: Arteris (NASDAQ:AIP) CEO Sells $277,940.04 in Stock

Arteris, Inc. (NASDAQ:AIP) CEO K Janac sold 11,452 shares of Arteris stock in a transaction on Monday, October 5th. The stock was sold at an average price of $24.27, for a total transaction of $277,940.04. Following the completion of the transaction, the chief executive officer directly owned 154,337 shares of the company’s stock, valued at $3,745,758.99. The trade was a 6.91% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

K Charles Janac also recently made the following trade(s):

• On Friday, October 2nd, K Janac sold 9,359 shares of Arteris stock. The shares were sold at an average price of $24.64, for a total transaction of $230,605.76.
• On Thursday, October 1st, K Janac sold 100,000 shares of Arteris stock. The shares were sold at an average price of $23.82, for a total transaction of $2,382,000.00.
• On Tuesday, September 1st, K Janac sold 100,000 shares of Arteris stock. The stock was sold at an average price of $20.75, for a total value of $2,075,000.00.
• On Tuesday, August 4th, K Janac sold 26,106 shares of Arteris stock. The stock was sold at an average price of $31.97, for a total value of $834,608.82.
• On Monday, August 3rd, K Janac sold 73,894 shares of Arteris stock. The stock was sold at an average price of $30.00, for a total value of $2,216,820.00.

Arteris Trading Down 2.4%

Shares of AIP stock opened at $22.84 on Friday. The company has a market cap of $1.12 billion, a PE ratio of -26.25 and a beta of 1.90. Arteris, Inc. has a 1 year low of $12.06 and a 1 year high of $50.26. The stock’s 50 day simple moving average is $24.44 and its two-hundred day simple moving average is $28.78. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.57 and a quick ratio of 1.57.

Arteris (NASDAQ:AIP) last released its earnings results on Thursday, August 6th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Arteris had a negative net margin of 46.70% and a negative return on equity of 295.96%. The company had revenue of $24.13 million for the quarter, compared to the consensus estimate of $23.48 million. Research analysts predict that Arteris, Inc. will post -0.68 earnings per share for the current year.

Key Stories Impacting Arteris

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris received an additional $3.3 million from the Trusted and Assured Microelectronics program to expand its third-party semiconductor IP security-assurance initiative with BAE Systems and SiFive. The funding supports Arteris’ role in securing hardware-design supply chains and may improve its positioning in government and advanced-chip projects. Arteris funding article
• Positive Sentiment: The funding has renewed the “undervalued” investment narrative around Arteris, with investors focusing on potential long-term demand for semiconductor security and the company’s strategic partnerships. Oppenheimer also maintained its Buy rating, reinforcing the constructive analyst view. Arteris undervalued narrative article Oppenheimer rating article
• Neutral Sentiment: CEO K. Charles Janac, COO Laurent Moll and VP Paul Alpern reported multiple share sales. Several transactions were associated with tax-withholding obligations when equity awards vested, which limits their value as a signal of weakening management confidence. Laurent Moll insider sale
• Negative Sentiment: Bayview Legacy LLC sold 100,000 shares, worth approximately $2.38 million. Unlike the executive transactions, the filing did not identify tax withholding as the reason, potentially adding selling pressure and investor caution, although the holder still retains a sizable position. Bayview Legacy insider sale
• Negative Sentiment: Arteris’ latest quarterly EPS loss was wider than analysts expected, and the company remains unprofitable. That fundamental backdrop may be offsetting optimism about the new funding and analyst support.

Institutional Investors Weigh In On Arteris

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in Arteris in the 2nd quarter valued at about $53,000. Versant Capital Management Inc grew its stake in Arteris by 33.7% in the 2nd quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock worth $56,000 after acquiring an additional 290 shares in the last quarter. Farther Finance Advisors LLC increased its position in shares of Arteris by 106.0% during the third quarter. Farther Finance Advisors LLC now owns 1,730 shares of the company’s stock worth $41,000 after acquiring an additional 890 shares during the period. Allworth Financial LP purchased a new position in shares of Arteris during the second quarter worth approximately $87,000. Finally, State of Wyoming purchased a new position in shares of Arteris during the second quarter worth approximately $165,000. Institutional investors own 64.36% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently commented on AIP shares. Rosenblatt Securities reiterated a “buy” rating and set a $38.00 price target on shares of Arteris in a report on Friday, August 7th. Weiss Ratings upgraded Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 21st. Oppenheimer began coverage on Arteris in a research note on Thursday, July 16th. They set an “outperform” rating and a $40.00 target price on the stock. Craig Hallum started coverage on Arteris in a research note on Monday, September 21st. They set a “buy” rating and a $30.00 price target for the company. Finally, Roth Capital assumed coverage on Arteris in a report on Tuesday, August 4th. They set a “buy” rating and a $40.00 price objective for the company. Six investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $39.43.

Arteris Company Profile

Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.

The company’s portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.